Uncovered research trends

  Global Troponin Market  The global troponin market consists of cardiac troponin T and I tests that are used for the assessment and diagnosis of myocardial infarction. Troponins play a vital role in assessing cardiac risk factors and heart-related issues among patients. The increasing geriatric population suffering from heart diseases, rising lifestyle-related disorders, and availability of advanced immunoassay tests are some key factors driving the growth of this market. Troponin tests are widely accepted as the gold standard biomarkers for the diagnosis of myocardial injury. These sensitive and cardiac-specific biomarkers help physicians in early detection of heart attacks leading to timely treatment intervention. Growing healthcare expenditure on cardiovascular disorders and expanding applications of troponin tests in hospitals, diagnostic laboratories, and ambulatory surgical centers are fueling market revenues. The Global troponin market is estimated to be valued at US$ ...

  Esoteric Testing Market  The esoteric testing market comprises specialized diagnostic tests such as allergy testing, endocrinology testing, hematology testing, infectious disease testing, immunology testing, and more. These tests are used to detect certain genetic disorders, metabolic problems, chronic diseases, and to monitor treatment for complex diseases. The demand for esoteric testing has increased over recent years owing to rising incidences of rare and complex diseases such as cancer, autoimmune disorders, and chronic infections. Esoteric tests help in the early detection of many rare diseases such as muscular dystrophy and lysosomal storage disorders. They enable timely diagnosis and treatment, thereby improving health outcomes. Moreover, advancements in specialized diagnostic technologies have made testing for rare conditions more accurate and cost-effective. The growing elderly population prone to develop complex healthcare disorders has also fueled the demand for ...

  North Africa Non-Invasive Prenatal Testing Market  Non-invasive prenatal testing (NIPT) involves the analysis of cell-free DNA from a pregnant woman’s blood sample to screen for fetal chromosomal abnormalities, such as Down syndrome, without risking the health of the fetus or mother. The technology has gained popularity in North Africa for providing accurate screening results within a few weeks of gestation as compared to other diagnostic tests.  The market is estimated to be valued at USD 7.3 billionin 2024 and is expected to exhibit a CAGR of 13.5% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the North Africa Non-Invasive Prenatal Testing market are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems, Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc. These players are focusing on new product launches and targeting the Middle East ...

Renal Biomarkers Market  Renal Biomarkers help in the detection and management of chronic kidney diseases. They are protein-based laboratory tests that can help predict the onset of acute kidney injury or monitor disease progression and treatment response in chronic kidney conditions. With rising incidences of diabetes, hypertension, and other lifestyle diseases leading to increased risk of kidney damage, the demand for renal biomarkers is growing substantially. The global Renal Biomarkers Market is estimated to be valued at US$ 1700.59 Mn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2024-2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing prevalence of renal diseases: One of the major factors driving the growth of the renal biomarkers market is the rising prevalence of chronic kidney diseases worldwide. According to statics, 1 in 10 adults across the globe are estimated to have chronic kidney d...

  Hyperthermia Cancer Treatment Market Hyperthermia involves raising the temperature of tumor tissues selectively to damage and kill cancer cells or to make tumor cells more sensitive to the effects of radiation and certain anticancer drugs. Hyperthermia treatments damage cancer cells by heating them through energy sources such as electromagnetic radiation, ultrasound, or circuits implanted in the body. These therapies have fewer side effects than other treatments such as chemotherapy. The global Hyperthermia Cancer Treatment Market is estimated to be valued at  US$ 187.05 Bn in 2023  and is expected to exhibit  a CAGR of 4.5%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends Advanced Targeting Technologies: One of the key trends driving growth in the hyperthermia cancer treatment market is the development of advanced targeting technologies that allow more selective heating of cancer c...

  Colorectal Cancer Screening Market  Colorectal cancer screening tests help detect early signs of colorectal cancer. These screening tests include fecal occult blood test (FOBT), fecal immunochemical test (FIT), flexible sigmoidoscopy, colonoscopy and DNA stool test. Colonoscopy is considered as the gold standard for screening as it allows examination of the entire colon and removal of polyps. The global Colorectal Cancer Screening Market is estimated to be valued at  US$14716.31 Mn in 2023  and is expected to exhibit a  CAGR of 10%  over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of colorectal cancer screening is one of the major factors driving the growth of this market. various awareness campaigns by governments and healthcare organizations regarding the importance of early detection of colorectal cancer through regular screening is encouraging populatio...

Cancer Diagnostics Market    Cancer diagnostics products assist in early detection and diagnosis of cancer with the help of tools and tests. Some common cancer diagnostics tools include biopsy, imaging tests, tumor biomarker tests, and liquid biopsy. These diagnostic tools offer non-invasive procedures to detect cancer at an early stage, monitor cancer treatment response, and determine the appropriate course of treatment. The rising adoption of personalized medicine and increasing preference for non-invasive diagnostic procedures are fueling the demand for advanced cancer diagnostic tools. The global Cancer Diagnostics Market is estimated to be valued at US$ 59.01 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The introduction of liquid biopsy has accelerated the growth of the cancer diagnostics market. Liquid biopsy is a non-invasive procedur...

Hematology Market Market Overview: The global Hematology Market is estimated to be valued at US$ 4537.5 million in 2023 and is expected to exhibit a CAGR of 7.80% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Hematology products play a crucial role in the diagnosis, treatment, and management of blood-related diseases and disorders. These products include various instruments, reagents, and consumables used in laboratories and healthcare settings for the analysis and study of blood and blood-forming organs. The rising prevalence of blood disorders and the increasing demand for accurate and efficient diagnostic techniques are driving the growth of the hematology market. Additionally, advancements in technology and the emergence of automated hematology analyzers are further fueling market growth. Market Key Trends: One key trend in the hematology market is the increasing adoption of point-of-care testing (POCT) devices. POCT dev...